Warren Banta, MD
Hematology & Oncology Physician in Los Angeles, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Warren Banta, MD filed 2,828 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Los Angeles, California, prescribing 66% generic.
- 3K
- Part D claims, 2023
- 66%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Warren Banta, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
2,828 Top 12% higher than 88% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Warren Banta, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Warren Banta, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in California
How Hematology & Oncology Physician compares to other specialties among California providers
Hematology & Oncology Physician ranks #79 among California's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Hematology & Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Warren Banta, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 1700 E CESAR E CHAVEZ AVE, Los Angeles, CA, 90033, with a listed phone of (323) 264-0430. NPI 1861695678 was issued on 06/08/2007.
Medicare Part D records for calendar year 2023 show 2,828 prescription claims written by this provider, covering 469 Medicare beneficiaries and totaling roughly $10.6 million in drug spend, split 34% brand-name and 66% generic by claim count, with an opioid prescribing rate of 0.9%.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1861695678 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/08/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Warren Banta, MD's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1861695678 is the unique 10-digit identifier CMS uses to link Banta across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Hospital and facility affiliations
Facilities where Warren Banta, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Warren Banta, MD. Source: openpaymentsdata.cms.gov.
Total received
$6.4K
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Warren Banta, MD. To verify Warren Banta, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
34% brand-name claims vs 66% generic, on 2,828 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,839
- Total Day Supply
- 103,531
- Brand vs Generic
- 34% brand / 66% generic
- Brand Drug Cost
- $9.9M
- Generic Drug Cost
- $689K
- Opioid Claims
- 25 (0.9% rate)
- Antibiotic Claims
- 18
Patient Demographics
- Average Patient Age
- 76.0 years
- Avg HCC Risk Score
- 2.78
- Gender Split
- 66% female / 34% male
- Age Distribution
- <65: 11, 65-74: 208, 75-84: 181, 85+: 69
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Warren Banta, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
471 claims
- Procrit
Procrit
198 claims
- Ondansetron Hcl 170
Ondansetron Hcl
170 claims
- Hydroxyurea 151
Hydroxyurea
151 claims
- Prochlorperazine M… 130
Prochlorperazine Maleate
130 claims
- Prednisone 122
Prednisone
122 claims
- Tamoxifen Citrate 101
Tamoxifen Citrate
101 claims
- Dexamethasone 98
Dexamethasone
98 claims
| Drug | Claims |
|---|---|
| Anastrozole | 471 |
| Procrit Epoetin Alfa | 198 |
| Ondansetron Hcl | 170 |
| Hydroxyurea | 151 |
| Prochlorperazine Maleate | 130 |
| Prednisone | 122 |
| Tamoxifen Citrate | 101 |
| Dexamethasone | 98 |
| Letrozole | 95 |
| Imbruvica Ibrutinib | 82 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Warren Banta, MD fits within the Hematology & Oncology Physician landscape nationally.
Warren Banta, MD's 2,828 claims are above the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Banta.
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is Warren Banta, MD's specialty? ▼
How much does Warren Banta, MD prescribe under Medicare Part D? ▼
Where is Warren Banta, MD located? ▼
What is Warren Banta, MD's NPI number? ▼
Does Warren Banta, MD prescribe more brand-name or generic drugs? ▼
Does Warren Banta, MD prescribe opioids? ▼
How many Hematology & Oncology Physician providers are there in the US? ▼
What drugs does Warren Banta, MD prescribe most often? ▼
Does Warren Banta, MD accept Medicare? ▼
How can I verify Warren Banta, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology